CompletedNot Applicable

Robot-assisted vs VATS Lobectomy for NSCLC

China320 participantsStarted 2017-06-01

Plain-language summary

Robot-assisted thoracoscopic surgery (RATS) was widely used in thoracic surgery, the surgical safety and feasibility of RATS lobectomy for NSCLC has been confirmed. However, the oncological long-term outcomes of RATS lobectomy has not been studied by randomized controlled trial, the purpose of this study is to determine whether RATS lobectomy would be as effective as VATS lobectomy on short-term and long-term outcomes.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. surgical indication for lobectomy;
✓. minimal invasive surgery;
✓. ASA (American Society of Anesthesiologists) stage: I-III;
✓. sign the informed consent. -

Exclusion criteria

✕. benign tumor or nodule;
✕. present of other malignancy;
✕. preoperative chemotherapy, radiotherapy, targeted therapy. -

What they're measuring

3-year overall survival (OS)

Timeframe: 3 year after surgery

Lymph node counts

Timeframe: postoperative in-hospital stay up to 30 days

Trial details

NCT IDNCT03134534

SponsorRuijin Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-05-31

View on ClinicalTrials.gov More Pulmonary Neoplasm trials